Point: Cesium-131: Ready for Prime Time

Brachytherapy

January 1, 2009

Dr. Bice argues that the potential advantages of Cesium-131 prostate brachytherapy are important to consider – especially to a clinical culture that may not be interested in a “new” brachytherapy isotope.

Long-Term Quality of Life in Prostate Cancer Patients Treated With Cesium-131

Authors: Glaser SM, Chen KS, Benoit RM, Smith RP, Beriwal S.

Dosimetric Evaluation of Permanent Prostate Brachytherapy Using Cs-131 Sources

Authors: Steven Kurtzman, M.D

Androgen Suppression Combined with Elective Nodal and Dose Escalated Radiation Therapy (the ASCENDE-RT Trial): An Analysis of Survival Endpoints for a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost to a Dose-Escalated External Beam Boost for High- and Intermediate-risk Prostate Cancer

W. James Morris, MD, FRCPC, W. James Morris MD, FRCPC, Scott Tyldesley, MD, FRCPC, …

Early Outcomes of Prostate Seed Implants with 131Cs: Toxicity and Initial PSA Dynamics from a Single Institution

Authors: C.S. Platta, D. Khuntia, J. Adkinson, E. Olson, S. Jennifer, H. Odau, R.R. Patel

Patient Information

Clinician Information

Cesium 131 Products

Why Theranostics?

Pipeline

Authors

Related posts

Long-Term Quality of Life in Prostate Cancer Patients Treated With Cesium-131

Dosimetric Evaluation of Permanent Prostate Brachytherapy Using Cs-131 Sources

Early Outcomes of Prostate Seed Implants with 131Cs: Toxicity and Initial PSA Dynamics from a Single Institution

Search

Recent Posts

Archives

Company

Brachytherapy

Theranostics

Newsletter

Email newsletter sign-up

Company

Newsletter

Email newsletter sign-up